Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Overview of Sexually Transmitted Diseases Rebecca A. Lillis, M.D. Assistant Professor of Medicine, Section of Infectious Diseases LSUHSC, New Orleans DISCLOSURE • I have no financial interests or other relationship with manufacturers of commercial products, suppliers of commercial services, or commercial supporters. My presentation will not include any discussion of the unlabeled use of a product or a product under investigational use. Major STDs Type of Agent Viruses Bacteria Fungi Protozoa Insects Name Disease Human Papillomavirus Warts Herpes Simplex Herpes Hepatitis B Hepatitis HIV AIDS Chlamydia Chlamydia Neisseria Gonorrheae Gonorrhea Treponema pallidum Syphilis Hemophilus ducreyi Chancroid Candida albicans Candidiasis Trichomonas vaginalis Trichomoniasis Sarcoptes scabii Scabies Syphilis • Cause: Spirochete - Treponema pallidum • Symptoms: Genital ulcer, rash • Diagnosis: – Dark Field exam – Blood test: RPR, VDRL,MHA-TP, IgG • Complications: – Late syphilis – Congenital syphilis – HIV transmission • Treatment - Penicillin Syphilis Stages and Manifestations Early Syphilis - 1st 12 months Primary Genital ulcer (chancre) Secondary - Generalized rash (palms & soles) Oral and genital lesions Alopecia Early latent - No signs or symptoms Late latent - Years Late - Neurosyphilis Cardiovascular syphilis Syphilis: Treatment • Early syphilis • Benzathine penicillin G (Bicillin L-A) 2.4 million units IM x 1 • Late latent • Benzathine penicillin G 2.4 million units IM per week x 3 • Neurosyphilis and cardiovascular syphilis • Intravenous penicillin G P&S Syphilis, Louisiana vs. U.S. 1981-1999 Cases/100,000 80 Louisiana 60 40 20 U.S. Year 2000 Objective 0 1987 1988 1989 1990 1991 1992 1993 1994 Year of Report 1995 1996 1997 1998 1999 Primary and secondary syphilis — Rates: United States, 1970–2004 and the Healthy People 2010 target Rate (per 100,000 population) 25 P&S Syphilis 2010 Target 20 15 10 5 0 1970 73 76 79 82 85 88 91 94 97 2000 03 Note: The Healthy People 2010 target for P&S syphilis is 0.2 case per 100,000 population. Louisiana rate 7.34 cases/ 100,000 is highest in nation for 2004 P&S Syphilis Cases in Louisiana Actual cases and projection to elimination goal 3500 Cases of P&S syphilis 3000 2500 2000 1500 1000 500 0 1991 1993 1995 1997 1999 Year of Report 2001 2003 2005 Rates of Syphilis in Industrialized Countries Country P&S Cases Rate Canada 248 0.8 England 117 0.4 Sweden 52 0.6 Denmark 39 0.7 U.S. (1996) 11,387 4.3 U.S. (1998) 6,993 2.6 U.S. (2005 goal) 1,000 0.4 Causes of Genital Ulcers ) Herpes ) Syphilis ) Chancroid Herpes • Herpes Simplex Virus (HSV) I and II • Symptoms: Painful blisters that recur • Complications (rare): – Spread to infants at delivery – Severe infections in AIDS patients Herpes: Treatment ) No cure ) Antivirals shorten duration, reduce frequency and severity of recurrences 5 Acyclovir (Zovirax) 5 Famcyclovir (Famvir) 5 Valcyclovir (Valtrex) ) Different dosages for initial treatment vs. recurrent or suppressive treatment Chancroid • Cause: Hemophilus ducreyi – Epidemiology: Uncommon in U.S., occurs in outbreaks • Symptoms: – Painful sore (may be multiple) that looks like chancre • Male:female ratio 10:1 • Treatment: Azithromycin, Ceftriaxone Causes of Genital Ulcers ) Herpes 5Painful, blister - ulcer, shallow, multiple, recurrent ) Syphilis 5Painless, single, not recurrent ) Chancroid 5Painful, single or multiple, not recurrent Causes of Urethral or Cervical Discharge ) Gonorrhea ) Chlamydia Gonorrhea • Cause: Neisseria gonorrheae • Symptoms: – Men - painful discharge from urethra – Women - cervical discharge • often no symptoms • Complications: – Women - Pelvic Inflammatory Disease (PID) Infertility, ectopic pregnancy - Infants - Eye infection "ophthalmia neonatorum" Tests for Gonorrhea ) Culture ) Gram Stain ) Non-culture tests 5 DNA Probe test (GenProbe) 5 PCR/LCR test Chlamydia • Cause: Chlamydia trachomatis • Symptoms: – Men – scant clear discharge from urethra – Women - cervical discharge • Usually no symptoms for men or women • Complications: – Women - Pelvic Inflammatory Disease (PID) Infertility, ectopic pregnancy - Infants – Pneumonia at 6 week age, eye infection Tests for Chlamydia ) Culture ) Non-culture tests 5 DFA test 5 EIA 5Lab -Chlamydiazyme, Microtrak, others 5Rapid - Clearview, TestPack, SureCell 5 DNA Probe test (GenProbe) 5 PCR and LCR tests Sensitivity of Different Tests for Chlamydia Test type PCR/LCR Culture DFA DNA Probe EIA 1 10 100 1000 10000 Number of organisms detectable 100000 1000000 Gonorrhea: Treatment ) Antibiotics for gonorrhea 5 Cefixime (Suprax) 400 mg PO x 1 5 Ciprofloxacin (Cipro) 500 mg PO x 1 5 Azithromycin (Zithromax) 2 gm PO x 1 5 Ceftriaxone (Rocephin) 125 mg IM x 1 ) Always treat for chlamydia also Chlamydia: Treatment ) Azithromycin 1 gm PO x 1 ) Doxycycline 100 mg PO BID x 7 days Rates of STDs Louisiana, 1992-1999 500 Cases/100,000 400 Chlamydia 300 Gonorrhea 200 100 P&S Syphilis 0 1992 1993 1994 1995 1996 Year of Report *projected from first 8 months 1997 1998 1999 Chlamydia — Rates: United States, 1984–2004 Louisiana’s rate for 2004 was 488.26 per 100,000, third highest in the nation Rate (per 100,000 population) 350 280 210 140 70 0 1984 86 88 90 92 94 96 98 2000 Note: As of January 2000, all 50 states and the District of Columbia had regulations requiring the reporting of chlamydia cases. 02 04 Gonorrhea — Rates: United States, 1970–2004 Louisiana’s rate for 2004 was 235.46 per 100,000 – second highest in the nation Rate (per 100,000 population) 500 Gonorrhea 2010 Target 400 300 200 100 0 1970 73 76 79 82 85 88 91 94 97 2000 Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000 population. 03 Rates of Gonorrhea and Chlamydia by Agegroup Louisiana, 1999 Cases per 100,000 2,500 Chlamydia Gonorrhea 2,000 1,500 1,000 500 0 5-9 10-14 15-19 20-24 25-34 35-44 Age Group 45-54 55-64 65+ Vaginitis ) Candidiasis ) Trichomoniasis ) Bacterial vaginosis Trichomoniasis • • • • Cause: Trichomonas vaginalis (protozoan) Symptoms: Frothy white vaginal discharge Diagnosis: Trich. on wet mount Complications: – ? Increased HIV transmission • Treatment: Metronidazole (Flagyl) • Very high recurrence rate after treatment Bacterial Vaginosis • Cause: Increase in Gardnerella vaginalis & others, decrease in lactobacilli • Symptoms: Malodorous vaginal discharge • Diagnosis: – Clue cells on wet mount – Positive "whiff test" • Complications: Premature delivery • Treatment: Metronidazole (Flagyl) • High recurrence rate after treatment Candidiasis • Cause: Candida albicans • Not an STD • Symptoms: Cheesy white adherent discharge • Treatment: – Fluconazole (Diflucan) – Terconazole (Terazol) – OTC creams Differentiating Among Causes of Vaginitis ) Candidiasis 5 Discharge is thick, adherent ) Trichomoniasis 5 Frothy discharge 5 Protozoa on wet prep ) Bacterial vaginosis 5 Thick, clear-white malodorous discharge 5 Clue cells on wet prep Treatment of Vaginitis ) Candidiasis 5 Diflucan 150 mg PO x 1 ) Trichomoniasis 5 Metronidazole (Flagyl) 2 gm PO ) Bacterial Vaginosis 5 Metronidazole (Flagyl) 500 mg BID x 7 days Syndromic Treatment for STDs Most common situations ) Genital ulcer - treat for syphilis 5 Benzathine penicillin 2.4 million units IM ) Urethral discharge/cervical discharge - treat for gonorrhea and chlamydia 5 Cefixime 400 mg or Cipro 500 mg AND 5 Azithromycin 1.0 gm or Doxycycline 100 mg b.i.d. x 7 days ) Vaginal discharge in female - treat for trichomoniasis and bacterial vaginosis 5 Metronidazole 2 gm Prevention Counseling ) Get partners treated ) Decrease number of partners ) Use a condom every time